Defiance Daily Target 2X Long RKLB ETF
RKLX · ETF
About RKLX
- Issuer
- Defiance
- Expense ratio
- 1.63%
- Assets under management
- $126.02M
- Inception
- Mar 12, 2025
- Asset class
- Equity
- Website
- defianceetfs.com
RKLX key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 3.36M
- Volume
- 2.07M
- Open price
- $8.60
- High today
- $9.34
- Low today
- $8.18
- 52 Week high
- $114.83
- 52 Week low
- $8.16
Defiance Daily Target 2X Long RKLB ETF (RKLX) at a glance
Defiance Daily Target 2X Long RKLB ETF (RKLX) last traded at $9.24, with a price-to-earnings ratio of 0.00.
Today the fund has traded between $8.18 and $9.34. The current price is 13.0% above the day's low and 1.1% below its high.
Volume so far is 2.07M shares, below the average of 3.36M shares a day.
Over the past year Defiance Daily Target 2X Long RKLB ETF has ranged from $8.16 to $114.83, and now sits 1% of the way up that range.
RKLX news
- Lekha Gupta
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.